DavidMCharlesMD

PubMed

• Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trial.
  Tramontana MG, Molinari AL, Konrad PE, Davis TL, Wylie SA, Neimat JS, May AT, Phibbs FT, Hedera P, Gill CE, Salomon RM, Wang L, Song Y, Charles D> ;J Parkinsons Dis. 2015-01-01
• Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease.
  Charles D, Konrad PE, Neimat JS, Molinari AL, Tramontana MG, Finder SG, Gill CE, Bliton MJ, Kao C, Phibbs FT, Hedera P, Salomon RM, Cannard KR, Wang L, Song Y, Davis TL> ;Parkinsonism Relat. Disord.. 2014-07-01
• Methods for Surgical Targeting of the STN in Early-Stage Parkinson's Disease.
  Camalier CR, Konrad PE, Gill CE, Kao C, Remple MR, Nasr HM, Davis TL, Hedera P, Phibbs FT, Molinari AL, Neimat JS, Charles D> ;Front Neurol. 2014-01-01
• Pilot study assessing the feasibility of applying bilateral subthalamic nucleus deep brain stimulation in very early stage Parkinson's disease: study design and ration...
  Charles D, Tolleson C, Davis TL, Gill CE, Molinari AL, Bliton MJ, Tramontana MG, Salomon RM, Kao C, Wang L, Hedera P, Phibbs FT, Neimat JS, Konrad PE> ;J Parkinsons Dis. 2012-01-01
• Neurotoxin injection for movement disorders.
  Charles D, Gill CE> ;Continuum (Minneap Minn). 2010-02-01
• Combined treatment with BTX-A and ITB for spasticity: case report.
  Gill CE, Andrade EO, Blair CR, Taylor HM, Charles D> ;Tenn Med. 2007-10-01
• Deep brain stimulation for Parkinson's disease: the Vanderbilt University Medical Center experience, 1998-2004.
  Gill CE, Konrad PE, Davis TL, Charles D> ;Tenn Med. 2007-04-01
• Continuation of long-term care for cervical dystonia at an academic movement disorders clinic.
  Gill, C. E.,Manus, N. D.,Pelster, M. W.,Cook, J. A.,Title, W.,Molinari, A. L.,Charles, D.> ;Toxins (Basel). 2013 Apr
• Join now to see all